glp-1 drugs for parkinson's disease drug shows little benefit people with | UCL News A new study finds GLP-1

doi:10.1210/clinem/dgad463 Lin S, Deng Y, Huang J, et al

Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas

Mimicking a natural hormone that regulates blood sugar and appetite, these drugs offer a multi-pronged approach to tackling obesity: Appetite Suppression: GLP-1 agonists significantly reduce hunger and increase feelings of fullness, leading to decreased food intake

[25] Those experiencing recurrent hypoglycaemia, severe gastrointestinal symptoms, or concerning new symptoms should contact their GP or diabetes specialist team promptly

Soluble fiber dissolves in water and forms a viscous gel in your digestive tract